MarketInOut Stock Screener Log In | Sign Up

Sun Pharma Advanced Research Company Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:57
Sun Pharma Advanced Research Company Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization55,743 mln
Float87.91 mln
Earnings Date11/02/2026

EPS

48.81
Exceptional

P / E

3.74
Deeply undervalued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

21.49
Highly suspicious

Relative Strength

57 / 100
Slightly ahead

Debt / Equity

0.42
Low leverage

Business Description

Founded in 2006 and headquartered in Mumbai, India, Sun Pharma Advanced Research Company is focused on discovering and developing new medicines for patients in India and around the world. The company concentrates its efforts on treating cancer and immune system disorders, with several drugs currently being tested in clinical trials targeting conditions such as leukemia, psoriasis, and eczema. Additional medicines aimed at hair loss and certain cancers are also in earlier stages of development and testing.

Key Fundamentals

EPS48.81
P/E3.74
ROE612
RPS58.82
ROIC144
ROA168
Interest Cover44.56
EBITDA, mln16,300
EV / EBITDA4.50
EV / EBIT4.53
Revenue, mln19,094
EV / Revenue3.84

Quote Details

Last 182.66
Change 3.42 (1.91%)
Open 180.63
Volume 434,665
Turnover 79,395,912
Average Volume 862,517

Financial Ratios

Pre-Tax Profit Margin83
Current Ratio2.47
Price / Book4.78
Price / Tangible Book5.05
Debt / Equity0.42
Price / Sales3.35

Financial Strength

Altman Z-Score8.35
Piotroski F-Score 7 / 9
Beneish M-Score21.49
Price to Graham Number0.96

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.89% 80 / 100   
1 Month -12.62% 26 / 100   
2 Months -18.64% 22 / 100   
6 Months 24.5% 84 / 100   
1 Year 41.16% 88 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog